Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05011500
Other study ID # CTOR20051GZA
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 1, 2021
Est. completion date May 1, 2022

Study information

Verified date August 2021
Source Cancer Research Antwerp
Contact Daan Nevens, PhD
Phone 0032034433737
Email Daan.Nevens@gza.be
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate the feasibility of using open masks or no masks in combination with optical surface scanning for radiotherapy in patients with head and neck cancer.


Recruitment information / eligibility

Status Recruiting
Enrollment 24
Est. completion date May 1, 2022
Est. primary completion date May 1, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients = 18 years old - Histologically confirmed head and neck cancer. - Patients treated with radiotherapy (RT) as primary treatment. - An Eastern Cooperative Oncology Group (ECOG) Performance Status grade of 0-1 as defined in Appendix 3. - Each subject must sign an informed consent form (ICF) indicating that he understands the purpose of and procedures required for the study and is willing to participate in the study. - Patients must be willing to comply with treatment plan and other study procedures Exclusion Criteria: - Patients with significantly altered mental status or with psychological, familial, sociological or geographical condition potentially hampering compliance with the study. - Patients who cannot stay still during fraction because of a disorder (e.g. Parkinson's disease)

Study Design


Related Conditions & MeSH terms


Intervention

Radiation:
Radiotherapy with Closed Mask
Radiotherapy for head and neck cancer, using a closed mask (full thermoplastic mask) to restrict patient movement.
Radiotherapy with Open Mask and Surface Scanning
Radiotherapy for head and neck cancer, using an open mask to restrict patient movement. Surface Scanning is used to monitor patient movement/positioning.
Radiotherapy with No Mask
Radiotherapy for head and neck cancer, without using a mask to restrict patient movement. Surface Scanning is used to monitor patient movement/positioning.

Locations

Country Name City State
Belgium GZA Ziekenhuizen campus Sint-Augustinus Antwerp

Sponsors (1)

Lead Sponsor Collaborator
Cancer Research Antwerp

Country where clinical trial is conducted

Belgium, 

References & Publications (10)

Ali I, Matthiesen C, Algan O, Thompson S, Bogardus C, Herman T, Ahmad S. Quantitative evaluation of increase in surface dose by immobilization thermoplastic masks and superficial dosimetry using Gafchromic EBT film and Monte Carlo calculations. J Xray Sci Technol. 2010;18(3):319-26. doi: 10.3233/XST-2010-0263. — View Citation

Bartlett FR, Donovan EM, McNair HA, Corsini LA, Colgan RM, Evans PM, Maynard L, Griffin C, Haviland JS, Yarnold JR, Kirby AM. The UK HeartSpare Study (Stage II): Multicentre Evaluation of a Voluntary Breath-hold Technique in Patients Receiving Breast Radiotherapy. Clin Oncol (R Coll Radiol). 2017 Mar;29(3):e51-e56. doi: 10.1016/j.clon.2016.11.005. Epub 2016 Nov 24. — View Citation

Cerviño LI, Pawlicki T, Lawson JD, Jiang SB. Frame-less and mask-less cranial stereotactic radiosurgery: a feasibility study. Phys Med Biol. 2010 Apr 7;55(7):1863-73. doi: 10.1088/0031-9155/55/7/005. Epub 2010 Mar 12. — View Citation

Dekker J, Rozema T, Böing-Messing F, Garcia M, Washington D, de Kruijf W. Whole-brain radiation therapy without a thermoplastic mask. Phys Imaging Radiat Oncol. 2019 Jul 25;11:27-29. doi: 10.1016/j.phro.2019.07.004. eCollection 2019 Jul. — View Citation

Li G, Lovelock DM, Mechalakos J, Rao S, Della-Biancia C, Amols H, Lee N. Migration from full-head mask to "open-face" mask for immobilization of patients with head and neck cancer. J Appl Clin Med Phys. 2013 Sep 6;14(5):243-54. doi: 10.1120/jacmp.v14i5.4400. — View Citation

Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7. Erratum in: CA Cancer J Clin. 2014 Sep-Oct;64(5):364. — View Citation

Stieler F, Wenz F, Shi M, Lohr F. A novel surface imaging system for patient positioning and surveillance during radiotherapy. A phantom study and clinical evaluation. Strahlenther Onkol. 2013 Nov;189(11):938-44. doi: 10.1007/s00066-013-0441-z. Epub 2013 Sep 27. — View Citation

van Herk M. Errors and margins in radiotherapy. Semin Radiat Oncol. 2004 Jan;14(1):52-64. Review. — View Citation

Wiant D, Squire S, Liu H, Maurer J, Lane Hayes T, Sintay B. A prospective evaluation of open face masks for head and neck radiation therapy. Pract Radiat Oncol. 2016 Nov - Dec;6(6):e259-e267. doi: 10.1016/j.prro.2016.02.003. Epub 2016 Feb 13. — View Citation

Zhao B, Maquilan G, Jiang S, Schwartz DL. Minimal mask immobilization with optical surface guidance for head and neck radiotherapy. J Appl Clin Med Phys. 2018 Jan;19(1):17-24. doi: 10.1002/acm2.12211. Epub 2017 Nov 9. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Positional Deviation Patient positioning and movement during treatment will be assessed using cone-beam computed tomopgraphy (CBCT). The position of the patient and target volumes measured by CBCT will be compared to computed tomography (CT) scans made during the initial simulation of treatment. CBCT-scans are made right before administering radiation and after radiation has been administered. Translational and rotational deviations will be measured and expressed in millimeters (for translational deviation) and degrees (for rotational deviation). Positional Deviation will be assessed from start of treatment period to end of treatment period (up to 7 weeks).
Secondary Patient Distress Patient Distress, measured every week using the Subjective Units of Distress Scale (SUDs), a scale of 0-10 where a higher number indicates a worse outcome. Patient distress will be assessed from start of treatment period to end of treatment period (up to 7 weeks).
Secondary Duration of Treatment Duration of treatment (in minutes), registered in radiotherapy software. Duration of treatment will be assessed from start of treatment period to end of treatment period (up to 7 weeks).
Secondary Radiotherapy Technician Satisfaction Personnel satisfaction, questioned weekly using a personnel satisfaction scale from 0 to 10, where a higher number indicates a better outcome. Radiotherapy technician satisfaction will be assessed from start of treatment period to end of treatment period (up to 7 weeks).
Secondary Radiation Dose In vivo dosimetry will be used to asses the accuracy of treatment. Using PerFRACTION™ in vivo dosimetry. Administered radiation doses will be measured for the target volume and expressed in Gray (Gy). Radiation dose will be assessed from start of treatment period to end of treatment period (up to 7 weeks).
See also
  Status Clinical Trial Phase
Completed NCT02960308 - Whole-Neck Computed Tomography Perfusion Scan in Imaging Patients With Head and Neck Tumors
Terminated NCT02602067 - 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients Phase 1
Completed NCT04277273 - Characteristics of a Maxillofacial Prosthesis Consultation Within Assistance Publique - Hopitaux de Paris N/A
Completed NCT03896906 - Preoxygenation With a High-flow Nasal Cannula or a Simple Mask Before General Anesthesia in Head and Neck Surgery N/A
Completed NCT01621295 - Assessing the Patient Experience in Cancer Care N/A
Active, not recruiting NCT03854838 - IMRT Combined With Toripalimab in Unresectable Locally Recurrent Nasopharyngeal Carcinoma. Phase 2
Completed NCT04151030 - Endoscopic Direct-PEG Placement in Patients Unable to Undergo Pull-PEG Procedure N/A
Completed NCT03012581 - Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer Types Phase 2
Active, not recruiting NCT04005521 - Randomized Study Regarding Preventive Jaw- and Swallowing Intervention for Patients With Head and Neck Cancer N/A
Completed NCT05590650 - A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients Phase 1
Terminated NCT03402737 - SBRT + Immunomodulating Systemic Therapy for Inoperable, Recurrent H&N N/A
Completed NCT04086849 - Analysis of Patterns of Recurrence in Head and Neck Cancer Using Clinicopathomic Markers
Completed NCT00001442 - A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer Phase 1
Recruiting NCT04477759 - Dose-Escalated Hypofractionated Adaptive Radiotherapy for Head and Neck Cancer Phase 1
Terminated NCT00423150 - Phase 2 Study of Temozolomide in Pre-Selected Advanced Aerodigestive Tract Cancers (Study P04273AM2)(TERMINATED) Phase 2
Recruiting NCT03757091 - Flexible Intubation Scope With or Without Video Laryngoscope in Supporting Endotracheal Tube Placement in Patients With Head and Neck Cancer Before Surgery N/A
Recruiting NCT04099290 - Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma
Withdrawn NCT04679233 - Feasibility and Safety of Aerobic Exercise for Head and Neck Cancer Patients N/A
Not yet recruiting NCT04267627 - Telemedicine Nurse-Led Intervention for Rural Cancer Survivors N/A
Completed NCT00666926 - Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic Neoplasms Phase 1